Correlations between serum cetuximab and EGFR-related markers, and skin disorders in head and neck cancer patients
Sign Up to like & getrecommendations! Published in 2021 at "Cancer Chemotherapy and Pharmacology"
DOI: 10.1007/s00280-020-04228-4
Abstract: Cetuximab inhibits epidermal growth factor receptor (EGFR) signaling in cancer and skin cells, thereby inducing anti-cancer effects and skin disorders. The present study aimed to evaluate the relationships between serum cetuximab and EGFR-related markers, and… read more here.
Keywords: related markers; egfr related; serum cetuximab; cancer ... See more keywords